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Abstract  12 
Clostridium difficile is the primary cause of antibiotic-associated diarrhea globally. In 13 
unfavourable environments the organism produces highly resistant spores which can survive 14 
microbicidal insult. Our previous research determined the ability of C. difficile spores to adhere 15 
to clinical surfaces; finding that spores had marked different hydrophobic properties and 16 
adherence ability. Investigation into the effect of the microbicide sodium dichloroisocyanurate 17 
on C. difficile spore transmission revealed that sub-lethal concentrations increased spore 18 
adherence without reducing viability. The present study examined the ability of spores to 19 
transmit across clinical surfaces and their response to an in-use disinfection concentration of 20 
1,000-ppm of chlorine-releasing agent sodium dichloroisocyanurate. In an effort to understand 21 
if these surfaces contribute to nosocomial spore transmission, surgical isolation gowns, 22 
hospital-grade stainless steel and floor vinyl were spiked with 1 × 106 spores/ml of two types 23 
of C. difficile spore preparations: crude spores and purified spores. The hydrophobicity of each 24 
spore type versus clinical surface was examined via plate transfer assay and scanning electron 25 
microscopy. The experiment was repeated and spiked clinical surfaces were exposed to 1,000-26 
ppm sodium dichloroisocyanurate at the recommended 10-min contact time. Results revealed 27 
that the hydrophobicity and structure of clinical surfaces can influence spore transmission and 28 
that outer spore surface structures may play a part in spore adhesion. Spores remained viable 29 
on clinical surfaces after microbicide exposure at the recommended disinfection concentration 30 
demonstrating ineffectual sporicidal action. This study showed that C. difficile spores can 31 
transmit and survive between varying clinical surfaces despite appropriate use of microbicides. 32 
IMPORTANCE  33 
Clostridium difficile is a healthcare-acquired organism and the causative agent of antibiotic-34 
associated diarrhoea. Its spores are implicated in faecal to oral transmission from contaminated 35 
surfaces in the healthcare environment due to their adherent nature. Contaminated surfaces are 36 
cleaned using high-strength chemicals to remove and kill the spores; however, despite 37 
appropriate infection control measures, there is still high incidence of C. difficile infection in 38 
patients in the US. Our research examined the effect of a high-strength biocide on spores of C. 39 
difficile which had been spiked onto a range of clinically relevant surfaces including isolation 40 
gowns, stainless steel and floor vinyl. This study found that C. difficile spores were able to 41 
survive exposure to appropriate concentrations of biocide; highlighting the need to examine 42 
the effectiveness of infection control measures to prevent spore transmission, and consideration 43 
of the prevalence of biocide resistance when decontaminating healthcare surfaces. 44 
Introduction  45 
The anaerobic spore-forming Gram-positive bacterium Clostridium difficile is the primary 46 
cause of antibiotic-associated diarrhea globally (1). C. difficile asymptomatically forms part of 47 
the microbiota of 1-3% healthy adults (2, 3); however, if the microbiota of the intestine is 48 
disrupted, for example as a result of broad- spectrum antibiotic treatment, colonisation of the 49 
colon by vegetative cells of C. difficile can proceed and escalate into the onset of C. difficile 50 
infection (CDI) (4). When fulminant infection ensues the patient will suffer from inflammation 51 
and diarrhoea. Further complications of CDI include pseudomembranous colitis, sepsis and the 52 
fatal toxic megacolon (5).   53 
Hypervirulent PCR ribotypes such as BI/027/NAP1 have spread intercontinentally and caused 54 
epidemics in Western countries further adding to CDI incidence (6, 7). Many reports highlight 55 
the increasing impact of CDI to public health and the associated economic burden. For 56 
example, mortality rates in the United States increased from 25 to 57 per million people for the 57 
periods 1999-2000 and 2006-2007, respectively (8). In total approximately 14,000 deaths 58 
occurred in 2007 and this statistic increased still further with an estimated 29,300 deaths in 59 
2011 (9). In 2008 alone the estimated cost related to CDI within the United States to health-60 
care facilities was $4.8 billion, ignoring the additional cost to other facilities such as care homes 61 
(10). A similar pattern of statistics can be seen in England, with an increase from 1,149 C. 62 
difficile-related deaths in 2001 rising to 7,916 in 2007 (11).  63 
In response to increasing CDI infection rates, stringent infection control procedures were 64 
implemented within hospital environments in England which resulted in a decline in mortality 65 
to 1,487 in 2012. This figure surpasses that of MRSA and non-specified Staphylococcus aureus 66 
infection mortality (262 in 2012) (12) and thus is still a major source of concern globally.  67 
Despite implementation of appropriate surveillance and infection control procedures the 68 
organism still causing significant levels of morbidity and mortality across nosocomial 69 
environments (13). 70 
Incidence of CDI is directly affected by the ability of C. difficile to produce resistant spores 71 
which can survive on organic and inorganic surfaces for months and remain viable (6). A major 72 
source of CDI and transmission in the healthcare environment is through the faecal to oral 73 
route; often via the contamination of surfaces. As many as 1 × 107 spores per gram faeces are 74 
released into the environment by infected patients through airborne dispersal and soiling further 75 
adding to the bioburden (14). Possible causes of transmission include inappropriate biocide 76 
use, lack of adherence to infection control guidelines and varying standards of practice across 77 
healthcare facilities globally (15, 16, 17). 78 
Chlorine-releasing agents (CRAs) are the predominant form of biocide used in healthcare 79 
facilities to disinfect surfaces; namely sodium hypochlorite (NaOCl) and sodium 80 
dichloroisocyanurate (NaDCC) (18). These microbicides are fast-acting in aqueous solutions 81 
and are relatively inexpensive (19). Low concentrations of 50-ppm available chlorine have 82 
shown to kill >99% of vegetative bacterial cells in vitro. In addition, when 275-ppm chlorine 83 
was applied to a clinical environment there was a significant reduction in hospital-acquired 84 
infections from non-spore forming bacteria (20, 21). However, the inactivation of spores 85 
requires much higher concentrations with the current recommendation for application of 86 
NaDCC in hospitals in England being 1,000-ppm available chlorine for 10 minutes to 87 
deactivate spores of C. difficile and Bacillus species (22, 23). Although the working 88 
concentration of NaDCC has shown to be effective in liquid culture (24), its application to 89 
working surfaces is less efficient for inactivation of spores (25) and this reduced activity is 90 
exacerbated by the presence of organic substances, such as bodily fluids and faeces, which 91 
have a neutralising effect on the biocide (26). The mechanism of action of chlorine-releasing 92 
biocides is poorly understood; however, it has been suggested that their action may be due to 93 
strong oxidative ability, their effect on cell membranes and inhibition of enzymatic reactions 94 
(27).  95 
Our previous study showed that adherence of C. difficile spores to inorganic surfaces increased 96 
when spores were exposed to sub-lethal concentrations (500-ppm available chlorine) of sodium 97 
dichloroisocyanurate (27). This increase was more pronounced for strain DS1748 (002 98 
ribotype) which is not known to produce an exosporium outer layer (28) and suggests that when 99 
spores are exposed to sub-lethal levels of biocide they may inadvertently become more 100 
adherent to inorganic surfaces. The purpose of the present study was to assess the transfer 101 
ability of C. difficile spores from clinical surfaces pre- and post-biocide exposure. Surfaces 102 
tested include hospital isolation gowns, hospital grade stainless steel and vinyl flooring 103 
routinely used within the United States. Spore recovery from spiked clinical surfaces was 104 
investigated using a plate transfer assay. Clinical surfaces spiked with spores were exposed to 105 
NaDCC to determine sporicidal efficacy and the presence of spores on each clinical surface 106 
pre and post NaDCC treatment was examined using scanning electron microscopy. 107 
Results 108 
Transfer of C. difficile spores from liquid form to hospital surgical gowns 109 
To examine the ability of C. difficile spores (U and P derived from strains DS1748, R20291 110 
and DS1813) to adhere to, and subsequently transfer from hospital surgical gowns, spores were 111 
applied directly to the surgical gowns in liquid for 10 s, 30 s, 1 min, 5 min and 10 min before 112 
being removed and discarded (Figure 1, Figure 4A and C). This experiment was designed to 113 
mimic transfer of infectious bodily fluids in the clinical setting and assess the potential for 114 
onward transmission to patients. There was no significant difference between the amount of 115 
spores (U and P) recovered from the gowns and the contact time of the spores to the gowns; 116 
suggesting that the process of spore transfer between surfaces occurred within the first 10 117 
seconds of contact with the gown (two-way ANOVA; p = 0.696). From Figure 1 it appears as 118 
though the recovery of DS1748 P Spores increased with contact time; however, this was not 119 
statistically significant (one-way ANOVA; p = 0.144). Generally, U spore recovery was 120 
significantly higher than that of P spores (two-way ANOVA; p < 0.001); however, the 121 
exception to this trend was the increased recovery of DS1813 P spores when compared to U 122 
spores of the same strain (one-way ANOVA; p < 0.001). There were no significant differences 123 
in spore recovery between DS1748 and R20291 for either U spores or P spores. 124 
 125 
Spore recovery from spiked clinical surfaces after direct contact with hospital gowns  126 
To establish whether hospital-grade stainless steel surfaces and vinyl flooring surfaces act as 127 
fomites for C. difficile spore transmission in the clinical setting, sterile sections of hospital 128 
surgical gowns were placed in direct contact with hospital-grade stainless steel and vinyl 129 
flooring spiked with 1 x 105 spores and spore recovery from the surgical hospital gowns 130 
assessed. The contact times were reduced to 10 s, 30 s and 1 min due to results presented in 131 
Figure 1 which confirm that the length of contact time had no significant effect on spore 132 
recovery. Similarly, there remained no significant difference in spore recovery from steel and 133 
vinyl between the contact times used and the amount of spores recovered from the strains 134 
examined (Figure 2) (two-way ANOVA; p = 0.892 and p = 0.904 for steel and vinyl, 135 
respectively). Spore recovery of U DS1748 was significantly higher from both stainless steel 136 
surfaces (one-way ANOVA; p = 0.034) and vinyl flooring (one-way ANOVA; p < 0.001) when 137 
compared to the other strains. DS1748 P spore recovery was higher on stainless steel (one-way 138 
ANOVA; p < 0.001) and vinyl flooring (one-way ANOVA; p < 0.001) than of R20291 and 139 
DS1813. DS1748 P spore recovery was approximately 10-fold higher than that of the U Spore 140 
equivalent (two-way ANOVA; p < 0.001).  141 
 142 
Sporicidal efficiency of sodium dichloroisocyanurate (NaDCC)  143 
Two types of spore suspension from three C. difficile strains (DS1748, R20291 and DS1813) 144 
were exposed to the recommended in-use concentration of NaDCC in solution (1,000-ppm) 145 
and spore viability was determined. From Figure 3 it can be seen that there was no recovery of 146 
spores which had been treated in liquid form and then spiked onto gowns. Moreover, recovery 147 
of NaDCC-treated U spores from the spiked  and directly-treated hospital surgical gowns were 148 
lower across the three strains tested when compared to non-treated spores, with the lowest 149 
relative recovery from strain R20291 (Student t-test; p < 0.005). Scanning Electron Microscopy 150 
(SEM) images in Figure 4A and 4C support this by showing adhered spores on the fibres of 151 
the gowns from strain R20291 before and after treatment with the recommended concentration 152 
of NaDCC. Interestingly, Figure 4B shows a single P spore of R20291 after NaDCC treatment 153 
with a visible exosporial layer, while Figure 4D shows a U spore of R20291 after treatment 154 
that has no visible evidence of an exosporial layer. These differences in spore exosporium show 155 
distinct morphological variations within the R20291 strain; but may not necessarily be as a 156 
result of NaDCC exposure. It is possible that any damage to the exosporium after NaDCC 157 
exposure is not visible via SEM (Figures 4B); thus there is a possibility that NaDCC may have 158 
chemically altered the exosporium structure without changing the spore’s overall three-159 
dimensional appearance (28).  160 
Decreased sporicidal activity was observed for strains tested with NaDCC on the varying 161 
clinical surfaces (Figure 3). Similar results were observed with DS1813 P spores, but not for P 162 
spores of DS1748 and R20291. There was detectable recovery of R20291 U Spores (~73 to 163 
~23 SFU) after NaDCC treatment on stainless steel; although this was not significantly 164 
different when compared to the lack of recovery of the other U strains tested (Mann-Whitney 165 
Test; p = 0.40).  Despite the lack of DS1813 spore recovery from stainless steel surfaces after 166 
NaDCC exposure (Figure 3C), spores were still present on the steel surfaces indicating lack of 167 
viability (Figure 5A).  168 
After NaDCC exposure no DS1748 or R20291 P spores were recovered from the vinyl flooring, 169 
whereas U spores from these strains were recovered (Figure 3A and B). SEM results revealed 170 
the presence of spores of both types on the vinyl (Figure 5B and D). The recovery of R20291 171 
U spores significantly decreased (Student’s t-test; p = 0.001) but not for DS1748 (Figure 3A 172 
and B). In contrast, the recovery of both U and P spores of DS1813 did not change significantly 173 
after NaDCC treatment (Student’s t-test; p > 0.05 for both U spores and P spores; Figure 3C).  174 
Discussion 175 
Gowns have been used by healthcare professionals to mitigate the risk of transmitting 176 
infectious materials between patients, hospital visitors and other healthcare workers (31). Many 177 
gowns have shown differences in barrier and textile performance and it is these variations that 178 
play a role in the dissemination of microorganisms across healthcare facilities (32). With the 179 
advent of modern technology single-use isolation gowns made from fluid-resistant materials, 180 
such as polypropylene, are now widely used as a form of barrier protection; however, there is 181 
some debate as to their efficiency (31, 33, 34). Our results demonstrated that C. difficile spores 182 
were able to transfer and adhere to fibres of the polypropylene spun gowns when spiked in a 183 
liquid medium. As there was no significant difference between the contact time of the spores 184 
and the recovery of spores from the gown, it appears as though the process of spore transfer 185 
occurred rapidly within the first 10 seconds of contact when examining spore recovery from 186 
spiked liquid, hospital grade stainless steel and vinyl flooring, respectively. This suggests a 187 
clear need to ensure appropriate decontamination of surfaces that a contaminated gown may 188 
come into direct contact with in a clinical setting.  189 
The ability of microorganisms to travel through fabrics is related to the physico-chemical 190 
properties of the gowns and the characteristics of the microorganism (32). Another interesting 191 
observation from this study is the rapid ability of the spores to move from one hydrophobic 192 
surface to another hydrophobic surface i.e. fluid-resistant gowns and stainless steel which 193 
suggests that the more hydrophobic spores interacted better with the stainless steel surfaces 194 
than the gowns (Table 1, Figure 1). Whether this is related to steel surface structure as opposed 195 
to gown structure, or the hydrophobic interactions between (i) the individual strains (which 196 
possess varying relative hydrophobicity; Table 1) (ii) the liquid and (iii) each test surface 197 
warrants further investigation at the molecular level. It is also clear that the single-use gowns 198 
act as fomites for C. difficile spore transmission. Not only do spores of all strains rapidly attach 199 
to the gown fibres from liquid and dry clinical surfaces but the single-use gowns are then 200 
ineffective at trapping spores within their fibres and preventing the onward transmission of 201 
spores as demonstrated by spore recovery from the gowns (Figures 1& 2). While this ability 202 
differs between strains, it does suggest that the adherence ability of the spore to individual 203 
gown fibres may be affected by spore hydrophobic properties and exosporium layer which is 204 
known to aid spore adherence on hospital surfaces (Table 1; 28).  Results also suggest that C. 205 
difficile spores, after microbicidal exposure to NaDCC at the recommended contact time and 206 
concentration, can continue to remain viable, adhere and transmit via hospital gowns (Figure 207 
4A & 4C; 1, 28, 35). This highlights the importance of ensuring that single-use surgical 208 
isolation gowns are used appropriately in infection prevention and control; i.e. that gowns are 209 
adorned upon entering and disposed of when exiting a single room to prevent onward spore 210 
transmission and incidence of CDI (36).   211 
Despite using recommended concentrations of NaDCC to decontaminate gowns, stainless steel 212 
surfaces and floor vinyl after spore exposure, spores were still visibly attached to each surface 213 
and were viable upon culture (Figures 4 & 5). Decontamination and appropriate cleaning of 214 
surfaces is critical in managing the spread of CDI to patients from spores (37). It can be 215 
speculated that the hydrophobic properties and weave of the gown fabric may have prevented 216 
exposure of spores to NaDCC which explains the increased spore recovery; however this would 217 
need to be examined further by exploring the use of fluorescence-based spore viability tests 218 
(38). The smooth surfaces of steel and vinyl would theoretically make NaDCC treatment more 219 
effective by increasing the test surface area; however, the occurrence of viable spores on both 220 
treated steel and vinyl surfaces conflicts with this hypothesis and clearly evidences spore 221 
resistance to NaDCC. This resistance was found for all three strains tested and was not limited 222 
to hypervirulent R20291 027 PCR ribotype strains (7) (Table 1). Our results confirm that 223 
working concentrations of sporicides (with active concentrations of chlorine) applied at the 224 
appropriate contact times may not kill C. difficile spores. The ability of microbicides, such as 225 
CRA’s, to kill C. difficile spores has been examined previously with similar results (7, 25, 26, 226 
38).  227 
Spores which possess an exosporium-like structure have been demonstrated to have increased 228 
adhesion to surfaces in vivo and in vitro; associated with increased hydrophobicity of the spore 229 
(28, 35, 39). The exact function of the exosporium-like structures on certain strains of C. 230 
difficile spores has yet to be fully elucidated; however, its role in adhesion to intestinal mucosal 231 
cells and in Bacillus spore adhesion has been more clearly defined (35, 39, 40). Our previous 232 
study established that exosporium-positive spores (DS1813) were more resistant to NaDCC at 233 
sub-lethal concentrations than exosporium-negative spores (DS1748) (1, 28), which appears to 234 
correlate with the theory that the exosporium layer confers a protective barrier to the spore, 235 
preventing it from being damaged (41). It has also been hypothesised that exposure of spores 236 
to NaDCC at inappropriate concentrations and contact times can alter and increase spore 237 
adhesion ability (1). In the present study, while we observed a lack of exosporium-negative 238 
DS1748 and exosporium-positive DS1813 spore recovery from hospital stainless steel, SEM 239 
image (Figure 5A) revealed the presence of DS1813 spores adhered onto the stainless steel 240 
surface, and the presence of possible damaged spores of DS1748 (Figure 5C). Indeed, the 241 
presence of a small number of spores following NaDCC treatment could still produce recovery 242 
of zero viable spores. Moreover, the viability of spores from all strains tested was also observed 243 
after NaDCC treatment of vinyl flooring (Figure 3). This strongly indicates that recovery of 244 
spores from stainless steel and vinyl, two very different materials, has been affected by biocide 245 
exposure, either due to biocidal killing or reduced spore adherence; however, the exact 246 
mechanism of spore adherence and biocidal activity of NaDCC upon the exosporium layer and 247 
spore ultrastructure has yet to be determined. 248 
As seen in Figures 4 and 5, there are exosporium-like projections present on R20291 spores 249 
that increase the material surface-spore contact area which correlates to data from other studies 250 
(41). It is possible that these projections may increase spore adherence and perhaps biocide 251 
resistance by protecting the core from chemical effects. Moreover, as NaDCC was completely 252 
effective when spores were exposed in liquid form (Figure 3) when compared to the spore 253 
recovery post exposure from spiked surfaces, attests to the potential the exosporium may have 254 
for protection of the spore from biocide exposure.  Interestingly, hypervirulent DS1813 and 255 
R20291 strains have shown an increased adherence ability throughout this study comparative 256 
to DS1748; suggesting exosporium- positive spores adhere better and more rapidly with first-257 
contact to the test surface (Table 1). Additionally, unpurified R20291 spores were recovered 258 
from all surfaces tested post-NaDCC exposure which demonstrates the spore’s ability to remain 259 
viable after biocide exposure (Fig 2 & 3). This concurs with previous studies that have 260 
demonstrated CRA resistance in PCR Ribotypes 017, 012 and 027 (R20291) (7). Mechanical 261 
removal to remove spores from clinical surfaces has been shown to be effective in studies, 262 
however, this may not be appropriate with gowns as they are designed for single-use; therefore 263 
effective and immediate disposal of surgical gowns after use needs to be considered when 264 
preventing transmission of CDI (6, 25). The impact of the microbicide upon spore structure 265 
and resistance warrants further research to fully understand the mechanisms of resistance and 266 
to establish up-to-date and effective decontamination protocols. Moreover, our research 267 
suggests that the C. difficile exosporium may play a key role in biocide resistance of spores and 268 
thus could be a potential target for development of novel sporicidal disinfectants. 269 
Materials and Methods 270 
Growth conditions, Clostridium difficile strains and spore production  271 
C. difficile cultures were incubated anaerobically at 37 oC  for 48 hours in a BugBox Plus 272 
anaerobic workstation (Ruskinn Technology Ltd. United Kingdom) using an 85% nitrogen, 273 
10% carbon dioxide and 5% hydrogen gas mix. Clinical isolates of C. difficile (PCR Ribotypes 274 
027 and 002) used in this study  are described in Table 1 and were obtained from the Anaerobic 275 
Reference Unit, University Hospital Wales, Cardiff, UK. Unless otherwise stated, all 276 
organisms were stored as spores at 4 oC. All experiments described were conducted in 277 
triplicate. C. difficile spores were produced according to two methods to generate 278 
unpurified/crude and purified spore preparations; spores produced via Perez et al 2005 (42) 279 
methodology were designated as unpurified (U) spores due to being harvested via water-280 
washing and containing vegetative and spore forms of the organism. These were deemed 281 
representative of C. difficile commonly encountered within clinical environments. Spores were 282 
produced on reduced brain heart infusion (BHI) agar and BHI broth (Oxoid Ltd, Basingstoke, 283 
United Kingdom) each supplemented with the germinant 0.1% (w/v) sodium taurocholate (28). 284 
Purified spores (P spores) were produced as described by Sorg and Sonenshein (2010) (43). 285 
Briefly, C. difficile strains were cultured on reduced BHI agar with 5 g/L yeast extract and 286 
0.1% L-cysteine and were examined after four days anaerobic incubation for characteristic 287 
colonies. Spores were harvested using sucrose density-washing. Spore purity was confirmed 288 
via phase contrast microscopy. Spore concentration was determined via drop count as described 289 
by Miles et al. (44) and mean spore-forming units (SFU) per ml calculated (28). 290 
Preparation of clinical surfaces   291 
Single–use hospital surgical gowns were produced by MediChoice, order no. 77752XL (45), 292 
made from fluid-resistant spunbond-meltdown-spunbond (SMS) polypropylene laminate at 293 
AAMI PB70:2012 (46) standard at level 2. To test the transfer of spores to and from the gowns, 294 
gowns were aseptically cut into 7×7 cm sections and testing performed within a drawn circle 295 
of 2 cm diameter to confer with the surface area of the hospital grade 2B stainless steel discs 296 
and vinyl flooring used in this study.  297 
Spore Transfer to Hospital Surgical Gowns 298 
To test the number of spores transferred to the hospital surgical gown after direct contact, U 299 
Spores and P Spores from strains DS1748, DS1813 and R20291 (Table 1) were produced at 1 300 
x104 spores/ml. From these, 100 µl were spiked onto the gown surface in triplicate experiments 301 
and allowed to remain in static contact for 10 s, 30 s, 1 min, 5 min and 10 min before being 302 
removed and discarded. After contact with spores, each section of gown was aseptically 303 
mounted onto a plunger pre-affixed with a steel disc so that the disc was aligned with the test 304 
area. A plate transfer test was then performed as described in Joshi et al., (28). A force of 100g 305 
was used as a simulated “touch” pressure.   306 
Spore Transfer from spiked “high-touch” surfaces to Hospital Surgical gowns 307 
To test the number of spores transferred to the surgical hospital gown from dry “high-touch” 308 
surfaces (hospital grade stainless steel and vinyl flooring), U and P spores were produced at 309 
concentrations of 1 x106 spores/ml. Sterilised hospital grade steel discs and vinyl flooring were 310 
inoculated with 100 µl of spores and allowed to dry completely for 120 min in a Category 2 311 
Biosafety laminar flow cabinet. Sections of gown were then placed in contact with the steel 312 
and vinyl under 100g pressure for 10 sec, 30 sec and 1 min and the gown was then pressed onto 313 
the appropriate agar plate for 10 sec at 100 g pressure (28). All agar plates were then incubated 314 
for 48 hrs at 37 oC under anaerobic conditions. Following incubation colonies were counted 315 
and SFU per ml were calculated. 316 
Exposure of Spores to Sodium Dichloroisocyanurate disinfectant 317 
Spore suspensions (U and P) from strains DS1748, R20291 and DS1813 at a concentration of 318 
1 x 106 spores per ml were exposed to 1000-ppm NaDCC for 10 minutes in liquid form 319 
(recommended contact time), neutralised with sodium thiosulfate and deposited onto sterile 320 
gowns. Spores were recovered as described previously (1, 22). Secondly, spores were also 321 
spiked onto the gown surface, as described in the spore transfer section above, and spores were 322 
spiked onto the surfaces of hospital stainless steel and hospital vinyl flooring, respectively, for 323 
each biological repeat and allowed to dry for 120 min in a Category 2 Biosafety laminar flow 324 
cabinet. The three spiked surfaces were then directly exposed to 100µl NaDCC at 1000-ppm 325 
for 10 minutes and neutralised with 1% sodium thiosulphate before plate transfer experiments 326 
were performed and spore recovery recorded. Three technical repeats of each experiment were 327 
performed. Control experiments where spores were exposed to sodium thiosulfate, sterile 328 
deionised water and NaDCC alone were also performed.   329 
Scanning electron microscopy 330 
Gowns, steel and vinyl were analysed using scanning electron microscopy for the presence of 331 
characteristic spores before and after treatment with NaDCC. Spores which had not been 332 
exposed to NaDCC were used as a comparative control. Test surfaces were sputter coated with 333 
metal using a gold palladium sputtering target (60% Au and 40% Pd from Testbourne Ltd) and 334 
argon as the sputtering gas. Images were taken on a scanning electron microscope (Zeiss Sigma 335 
HD Field Emission Gun Analytical SEM) using an accelerating voltage of 5 kV. Over 100 336 
individual spores were viewed per sample at magnifications of x 4, 890 and x 83,380. 337 
Statistical Analysis 338 
Data are expressed as means ± SEM. Paired T-tests, One way ANOVA, 2-way ANOVA and 339 
Mann-Whitney U tests were performed using Minitab 17. 340 
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Tables: Table 1 Clostridium difficile strains used in the present study. 498 
C. difficile 
strain 
PCR 
Ribotype 
Source Exosporium 
Presence 
Relative 
Hydrophobicity 
 
DS1813 027 Hinchingbrooke Positive 77% 
R20291 027 Stoke-
Mandeville 
Positive 62% 
DS1748 002 Leeds Negative 14% 
Figures & Legends 499 
 500 
Figure 1: Recovery of two different C. difficile spore types (Unpurified [U] and Purified [P]) 501 
from spiked hospital surgical gowns. Spores were derived from strains DS1748, R20291 and 502 
DS1813 and spores recovered after being exposed to the gowns at contact times ranging from 503 
10 s to 10 min. Plots represent mean ± SEM (n = 3).  504 
 505 
Figure 2: Transmission ability of two different C. difficile spore types between clinical surfaces. 506 
Spores derived from strains DS1748, R20291 and DS1813 were spiked onto hospital stainless 507 
steel and vinyl surfaces and their ability to transfer to hospital surgical gowns was tested. 508 
Unpurified (U) and purified (P) spores were recovered via transfer test from (A) hospital grade 509 
stainless steel and (B) hospital vinyl flooring using hospital surgical gowns applied at a 510 
pressure of 100g.  Contact times ranged at 10s, 30 s and 1 min.  Plots represent mean ± SEM 511 
(n = 3).  512 
 513 
Figure 3:  Recovery of unpurified and purified C. difficile spores from spiked clinical surfaces 514 
after treatment with 1000-ppm NaDCC for 10 min. Transfer testing was used to recover U and 515 
P spores of C. difficile strains (A) DS1748, (B) R20291 and (C) DS1813 from hospital surgical 516 
gowns after contact with: spores suspended in NaDCC applied to sterile gown, spiked gown 517 
exposed to NaDCC, spiked hospital stainless steel and hospital vinyl flooring exposed to 518 
NaDCC. The inoculum was used as the positive control (water only) and was also suspended 519 
in sodium thiosulfate to ensure no cross reactivity. Plots represent mean ± SEM (n = 3). 520 
 521 
Figure 4: Scanning electron micrographs of C. difficile spores present on spiked hospital 522 
surgical gowns before and after treatment with NaDCC at 1,000-ppm for 10 min. Images depict 523 
untreated (A) R20291 U spores on surgical gown fibres and (B) R20291 P single spore and 524 
NaDCC treated (C) R20291 U spores on surgical gown fibres, (D) R20291 U single spore. 525 
Arrows highlight spores adhered to gown fibres before (A) and after NaDCC treatment in (C), 526 
and morphological changes in exosporium before (B) and after NaDCC treatment (D). Scale 527 
bars in B and D are 200 nm, in A 2 µm, and in C 10 µm.  528 
 529 
Figure 5: Scanning electron micrographs of C. difficile spores present on spiked hospital 530 
stainless steel and floor vinyl before and after treatment with NaDCC at 1,000 ppm for 10 min. 531 
Images are NaDCC-treated (A) DS1813 P spores on stainless steel; (B) DS1748 U Spores on 532 
floor vinyl; (C) DS1748 U spores on stainless steel and (D) R20291 U spores on floor vinyl. 533 
Arrows highlight areas in the exosporium layer. Scale bars in A, B and D are 1µm, and in C 534 
200 nm.   535 
 536 
